Callan Family Office’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Buy
4,522
+5
+0.1% +$2.11K 0.03% 429
2026
Q1
$2.14M Sell
4,517
-133
-3% -$67K 0.05% 338
2025
Q4
$2.17M Buy
4,650
+714
+18% +$331K 0.05% 338
2025
Q3
$1.68M Sell
3,936
-322
-8% -$125K 0.05% 287
2025
Q2
$1.63M Buy
4,258
+2,149
+102% +$774K 0.05% 302
2025
Q1
$729K Sell
2,109
-145
-6% -$46.6K 0.05% 254
2024
Q4
$677K Buy
+2,254
New +$788K 0.04% 311

Other funds holding HCA

Callan Family Office's HCA Position: Q2 2026 in Review

Callan Family Office increased its HCA Healthcare (HCA) stake by 0.11% in Q2 2026, buying an estimated $2.11K and bringing the position to 4,522 shares worth $1.76M. The position accounts for 0.03% of the portfolio, ranked #429.

Callan Family Office first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.17M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Callan Family Office held 4,522 shares of HCA Healthcare worth $1.76M as of Q2 2026.
  • Callan Family Office bought 5 HCA Healthcare shares in Q2 2026, an estimated $2.11K.
  • HCA Healthcare made up 0.03% of Callan Family Office's portfolio in Q2 2026, its #429 holding.
  • Callan Family Office first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's HCA Healthcare position peaked at $2.17M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.